‘We’re trying to provide care focused not just on cancer treatment, but also on the psychological trauma they’ve experienced from war’
Vaccination after COVID improves immunity; ivermectin fails in major trial
While people recovering from COVID-19 usually get some immune defenses against reinfection, they get additional protection from vaccines, especially against serious illness, according to two studies published Thursday in The Lancet Infectious Diseases. A study of 22,566 people in Brazil who had recovered from COVID found that all four vaccines used there – from Sinovac Biotech, AstraZeneca, Johnson & Johnson and Pfizer/BioNTech – provided significant additional protection. “One dose of hybrid immunity was associated with an additional 94% lower risk of COVID-19 hospitalization and two doses of hybrid immunity with an additional 90% lower risk of COVID-19 hospitalization,” compared with natural immunity alone, the researchers said. . †
Comments are closed.